BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11384762)

  • 1. Development of a new method of analysing chemotactic deactivation of human neutrophil granulocytes.
    Bock O; Mrowietz U
    J Biochem Biophys Methods; 2001 May; 48(3):257-68. PubMed ID: 11384762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 and neutrophil leucocytes: adhesion, spreading, polarisation, random motility, chemotaxis and deactivation in assays using 'sparse-pore' polycarbonate (nuclepore) membranes in the Boyden chamber.
    Bignold LP; Harkin DG; Rogers SD
    Int Arch Allergy Immunol; 1992; 97(4):350-7. PubMed ID: 1597355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte and neutrophil chemotaxis in vitro employing 51Cr-labelled leukocytes.
    Ternowitz T
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):189-93. PubMed ID: 4083015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotaxis of polymorphonuclear leukocytes in whole blood in the 'sparse-pore' polycarbonate (Nuclepore) membrane/Boyden chamber assay.
    Rice JE; Bignold LP
    J Immunol Methods; 1992 Apr; 149(1):121-5. PubMed ID: 1583311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells.
    Kownatzki E; Kapp A; Uhrich S
    Clin Exp Immunol; 1988 Oct; 74(1):143-8. PubMed ID: 2851397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of chemo-attraction of polymorphonuclear leukocytes towards N-formyl peptide studied with a novel polycarbonate (Nucleopore) membrane in the Boyden chamber.
    Bignold LP
    Experientia; 1988 Jun; 44(6):518-21. PubMed ID: 3378594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of leukocyte migration: improvement of a method.
    Sunder-Plassmann G; Hofbauer R; Sengoelge G; Hörl WH
    Immunol Invest; 1996; 25(1-2):49-63. PubMed ID: 8675234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
    Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
    J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
    Partsch G; Schwarzer C
    J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
    Loike JD; el Khoury J; Cao L; Richards CP; Rascoff H; Mandeville JT; Maxfield FR; Silverstein SC
    J Exp Med; 1995 May; 181(5):1763-72. PubMed ID: 7722453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic properties of rat immunoglobulins and immune complexes.
    Arashi M; Sibille Y; Merrill WW; Rits M; Bazin H; Vaerman JP
    Infect Immun; 1989 Feb; 57(2):452-7. PubMed ID: 2643569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes.
    van Zandbergen G; Hermann N; Laufs H; Solbach W; Laskay T
    Infect Immun; 2002 Aug; 70(8):4177-84. PubMed ID: 12117926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.
    Mrowietz U; Schröder JM; Christophers E
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1223-8. PubMed ID: 3390181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.
    Dunzendorfer S; Kaneider N; Rabensteiner A; Meierhofer C; Reinisch C; Römisch J; Wiedermann CJ
    Blood; 2001 Feb; 97(4):1079-85. PubMed ID: 11159540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of chemotactic, chemotactic movement-inhibiting and random movement-inhibiting effects of interleukin-1 alpha and beta, tumour necrosis factors alpha and beta and interferon gamma on human neutrophils in assays using 'sparse-pore' polycarbonate (Nuclepore) membranes in the Boyden chamber.
    Bignold LP; Ferrante A; Haynes DR
    Int Arch Allergy Appl Immunol; 1990; 91(1):1-7. PubMed ID: 2107149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.